Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Apr 24 2025

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/oxygenta-pharmaceutical-limited-press-release-apr-24-2025

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aakanksha M Chawda

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases